Alpha Teknova, Inc. TKNO Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000950170-25-068050
cik 1850902
name ALPHA TEKNOVA, INC.
sic 2835
countryba US
stprba CA
cityba HOLLISTER
zipba 95023
bas1 2451 BERT DRIVE
bas2
baph 8316371100
countryma US
stprma CA
cityma HOLLISTER
zipma 95023
mas1 2451 BERT DRIVE
mas2
countryinc US
stprinc DE
ein 943368109
former
changed
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250509
accepted 2025-05-09 16:17:00.0
prevrpt 0
detail 1
instance tkno-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000950170-25-068050 20241231 Accounts Receivable Net Current 4312000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3377000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Deferred Income Taxes And Tax Credits 21000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Deferred Income Tax Liabilities Net 827000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Deferred Income Tax Liabilities Net 848000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Earnings Per Share Diluted -0.2000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Increase Decrease In Accounts Payable 740000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Intangible Assets Net Excluding Goodwill 13091000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Intangible Assets Net Excluding Goodwill 12804000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Interest And Fee Income Other Loans Held For Sale 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Liabilities 35388000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Long Term Debt Current 4045000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Net Cash Provided By Used In Investing Activities 3824000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Non Cash Lease Expense 47000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Nonoperating Income Expense -145000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Operating Expenses 10195000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Operating Lease Right Of Use Asset 15767000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Operating Lease Right Of Use Asset 15409000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Payments Of Stock Issuance Costs 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Proceeds From Stock Options Exercised 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Revenue From Contract With Customer Excluding Assessed Tax 7266000.0000 USD 1 us-gaap/2024 Product Or Service= Lab Essentials;
0000950170-25-068050 20240331 Revenue From Contract With Customer Excluding Assessed Tax 306000.0000 USD 1 us-gaap/2024 Product Or Service= Other Product;
0000950170-25-068050 20250331 Revenue From Contract With Customer Excluding Assessed Tax 9795000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Stockholders Equity 82394000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Stockholders Equity 201780000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068050 20241231 Accrued Liabilities Current 4541000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Additional Paid In Capital 200924000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Amortization Of Discount On Short- Term Investments 0.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20241231 Cash And Cash Equivalents At Carrying Value 3708000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 28484000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-068050 20250331 Common Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Common Stock Shares Authorized 490000000.0000 shares 0 us-gaap/2024
0000950170-25-068050 20241231 Common Stock Shares Outstanding 53409727.0000 shares 0 us-gaap/2024
0000950170-25-068050 20250331 Earnings Per Share Diluted -0.0900 USD 1 us-gaap/2024
0000950170-25-068050 20240331 General And Administrative Expense 7381000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Gross Profit 3007000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Income Tax Expense Benefit 22000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Increase Decrease In Accrued Liabilities -1017000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Increase Decrease In Other Noncurrent Assets And Liabilities Net -63000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Net Cash Provided By Used In Investing Activities 13000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Net Cash Provided By Used In Operating Activities -6558000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Net Income Loss -8097000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Operating Lease Liability Current 1850000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Other Adjustment To Loan Exit Fee 0.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Other Operating Activities Cash Flow Statement -24000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Payments To Acquire Property Plant And Equipment 206000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Payments To Acquire Short Term Investments 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Proceeds From Sale Of Property Plant And Equipment 125000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Proceeds From Sale Of Property Plant And Equipment 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Property Plant And Equipment Net 44728000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Recognition Of Operating Lease Liabilities 1306000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Repayment Of Financed Insurance Premiums 306000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Retained Earnings Accumulated Deficit -123176000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Revenue From Contract With Customer Excluding Assessed Tax 8870000.0000 USD 1 us-gaap/2024 Geographical= U S;
0000950170-25-068050 20250331 Accounts Payable Current 1555000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Accrued Interest Income On Short Term Investments 0.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Accrued Interest Income On Short Term Investments -54000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Allowance For Doubtful Accounts Receivable Current 128000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Amortization Of Financing Costs 84000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Assets Current 39733000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20231231 Common Stock Shares Outstanding 40793848.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20241231 Common Stock Shares Outstanding 53409727.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20241231 Common Stock Value 1000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Earnings Per Share Basic -0.2000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 General And Administrative Expense 5492000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Income Taxes Paid 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Income Taxes Paid 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Inventory Net 6573000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Liabilities And Stockholders Equity 118769000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Net Income Loss -4645000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068050 20241231 Operating Lease Liability Noncurrent 14884000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Other Accrued Liabilities Noncurrent 10000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Short Term Investments 26688000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20231231 Stockholders Equity -91786000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068050 20241231 Stockholders Equity -118531000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068050 20250331 Amortization Of Intangible Assets 287000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities 5000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Cash And Cash Equivalents At Carrying Value 3377000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 21596000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Debt Issuance Costs Included In Accrued Liabilities 25000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Depreciation Depletion And Amortization 1636000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Gross Profit 2209000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Increase Decrease In Accounts Payable 133000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Increase Decrease In Accounts Receivable 1349000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Increase Decrease In Other Noncurrent Assets And Liabilities Net -117000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -174000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Intangible Assets Net Excluding Goodwill 2054000.0000 USD 0 us-gaap/2024 Finite Lived Intangible Assets By Major Class= Customer Relationships;
0000950170-25-068050 20250331 Liabilities Current 7045000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Nonoperating Income Expense 341000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Operating Income Loss -4964000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Operating Lease Liability Current 1800000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Operating Lease Liability Noncurrent 14506000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Other Adjustment To Loan Exit Fee -485000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Payment Of Exit Fee Costs 0.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Proceeds From Issuance Of Senior Long Term Debt 1110000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Proceeds From Maturities Prepayments And Calls Of Shortterm Investments 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Provision For Doubtful Accounts 45000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Revenue From Contract With Customer Excluding Assessed Tax 1718000.0000 USD 1 us-gaap/2024 Product Or Service= Clinical Solutions;
0000950170-25-068050 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1162000.0000 USD 1 us-gaap/2024 Product Or Service= Clinical Solutions;
0000950170-25-068050 20250331 Revenue From Contract With Customer Excluding Assessed Tax 516000.0000 USD 1 us-gaap/2024 Product Or Service= Other Product;
0000950170-25-068050 20240331 Selling And Marketing Expense 1667000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Share Based Compensation 852000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Stockholders Equity -99883000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068050 20250331 Weighted Average Number Of Shares Outstanding Basic 53421533.0000 shares 1 us-gaap/2024
0000950170-25-068050 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1307000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1307000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068050 20250331 Common Stock Shares Issued 53437060.0000 shares 0 us-gaap/2024
0000950170-25-068050 20250331 Common Stock Shares Outstanding 53437060.0000 shares 0 us-gaap/2024
0000950170-25-068050 20250331 Common Stock Value 1000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Debt Issuance Costs Included In Accrued Liabilities 100000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -8131000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 4000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Inventory Write Down 437000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Liabilities And Stockholders Equity 113993000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Liabilities Current 11211000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Long Term Debt 9443000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Net Income Loss -4645000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Other Accrued Liabilities Noncurrent 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Other Assets Noncurrent 1382000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Other Assets Noncurrent 1319000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-068050 20241231 Property Plant And Equipment Net 45753000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Recognition Of Operating Right Of Use Lease Asset 116000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Repayment Of Financed Insurance Premiums 56000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Revenue From Contract With Customer Excluding Assessed Tax 9272000.0000 USD 1 us-gaap/2024 Geographical= U S;
0000950170-25-068050 20231231 Stockholders Equity 90036000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Stockholders Equity 183261000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068050 20240331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 29539.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20250331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 22538.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20250331 Stock Issued During Period Shares Stock Options Exercised 4795000.0000 shares 1 us-gaap/2024 Award Type= Employee Stock Option;
0000950170-25-068050 20240331 Weighted Average Number Of Shares Outstanding Basic 40804885.0000 shares 1 us-gaap/2024
0000950170-25-068050 20250331 Net Cash Provided By Used In Operating Activities -4103000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Other Operating Activities Cash Flow Statement -10000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Payment Of Exit Fee Costs 1110000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Payments To Acquire Property Plant And Equipment 112000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-068050 20241231 Allowance For Doubtful Accounts Receivable Current 83000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Assets 118769000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3708000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -6888000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -331000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Deferred Income Taxes And Tax Credits -35000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Gain Loss On Disposition Of Assets1 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Income Tax Expense Benefit -34000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Increase Decrease In Accounts Receivable 619000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Increase Decrease In Inventories -478000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Increase Decrease In Inventories 209000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Intangible Assets Net Excluding Goodwill 10750000.0000 USD 0 us-gaap/2024 Indefinite Lived Intangible Assets By Major Class= Trade Names;
0000950170-25-068050 20240331 Interest Income Expense Net -145000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Interest Paid Net 366000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Long Term Debt 12989000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Net Cash Provided By Used In Financing Activities -52000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Prepaid Expense And Other Assets Current 1271000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Proceeds From Issuance Of Senior Long Term Debt 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Recognition Of Operating Right Of Use Lease Asset 1293000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Research And Development Expense 860000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Research And Development Expense 552000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Revenue From Contract With Customer Excluding Assessed Tax 8117000.0000 USD 1 us-gaap/2024 Product Or Service= Lab Essentials;
0000950170-25-068050 20250331 Selling And Marketing Expense 1640000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Stockholders Equity 83378000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Stockholders Equity -123176000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068050 20250331 Accounts Receivable Net Current 5616000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Accrued Liabilities Current 3640000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Additional Paid In Capital 201780000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Adjustments To Additional Paid In Capital Warrant Issued 0.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Amortization Of Discount On Short- Term Investments -184000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20240331 Amortization Of Intangible Assets 287000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities 166000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Common Stock Shares Authorized 490000000.0000 shares 0 us-gaap/2024
0000950170-25-068050 20250331 Cost Of Goods And Services Sold 6788000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Depreciation Depletion And Amortization 1580000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Earnings Per Share Basic -0.0900 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Gain Loss On Disposition Of Assets1 -49000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4623000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Intangible Assets Net Excluding Goodwill 2341000.0000 USD 0 us-gaap/2024 Finite Lived Intangible Assets By Major Class= Customer Relationships;
0000950170-25-068050 20250331 Interest And Fee Income Other Loans Held For Sale 485000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Inventory Net 6801000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Liabilities 36375000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Net Cash Provided By Used In Financing Activities -343000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Net Income Loss -8097000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068050 20250331 Non Cash Lease Expense 30000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20250331 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Preferred Stock Shares Authorized 10000000.0000 shares 0 us-gaap/2024
0000950170-25-068050 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-068050 20250331 Proceeds From Maturities Prepayments And Calls Of Shortterm Investments 6000000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Proceeds From Stock Options Exercised 4000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Revenue From Contract With Customer Excluding Assessed Tax 420000.0000 USD 1 us-gaap/2024 Geographical= Non Us;
0000950170-25-068050 20241231 Stockholders Equity 200924000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068050 20250331 Stockholders Equity 78605000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20250331 Stock Issued During Period Shares Stock Options Exercised 4795.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20250331 Weighted Average Number Of Diluted Shares Outstanding 53421533.0000 shares 1 us-gaap/2024
0000950170-25-068050 20241231 Accounts Payable Current 825000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 852000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 852000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068050 20240331 Adjustments To Additional Paid In Capital Warrant Issued 132000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Adjustments To Additional Paid In Capital Warrant Issued 132000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068050 20250331 Amortization Of Financing Costs 86000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Assets 113993000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Assets Current 42776000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-068050 20241231 Common Stock Shares Issued 53409727.0000 shares 0 us-gaap/2024
0000950170-25-068050 20250331 Revenue From Contract With Customer Excluding Assessed Tax 523000.0000 USD 1 us-gaap/2024 Geographical= Non Us;
0000950170-25-068050 20240331 Common Stock Shares Outstanding 40823387.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20250331 Common Stock Shares Outstanding 53437060.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20240331 Cost Of Goods And Services Sold 7081000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Increase Decrease In Accrued Liabilities -1724000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Intangible Assets Net Excluding Goodwill 10750000.0000 USD 0 us-gaap/2024 Indefinite Lived Intangible Assets By Major Class= Trade Names;
0000950170-25-068050 20250331 Interest Income Expense Net -144000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Interest Paid Net 353000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Inventory Write Down -91000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Long Term Debt Current 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Operating Expenses 7971000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Operating Income Loss -7986000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20240331 Payments Of Stock Issuance Costs 37000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Payments To Acquire Short Term Investments 1970000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20241231 Preferred Stock Par Or Stated Value Per Share 0.0000 USD 0 us-gaap/2024
0000950170-25-068050 20250331 Preferred Stock Shares Authorized 10000000.0000 shares 0 us-gaap/2024
0000950170-25-068050 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-068050 20241231 Prepaid Expense And Other Assets Current 1267000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Provision For Doubtful Accounts 7000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Recognition Of Operating Lease Liabilities 116000.0000 USD 1 0000950170-25-068050
0000950170-25-068050 20241231 Retained Earnings Accumulated Deficit -118531000.0000 USD 0 us-gaap/2024
0000950170-25-068050 20240331 Revenue From Contract With Customer Excluding Assessed Tax 9290000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20231231 Stockholders Equity 181822000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068050 20241231 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068050 20240331 Weighted Average Number Of Diluted Shares Outstanding 40804885.0000 shares 1 us-gaap/2024
0000950170-25-068050 20240331 Share Based Compensation 1307000.0000 USD 1 us-gaap/2024
0000950170-25-068050 20250331 Short Term Investments 22896000.0000 USD 0 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Other Adjustment To Loan Exit Fee 0000950170-25-068050 1 0 monetary D D Other adjustment to loan exit fee Other adjustment to loan exit fee
Allowance For Doubtful Accounts Receivable Current us-gaap/2024 0 0 monetary I C Accounts Receivable, Allowance for Credit Loss, Current Amount of allowance for credit loss on accounts receivable, classified as current.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Proceeds From Stock Options Exercised us-gaap/2024 0 0 monetary D D Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Short Term Investments us-gaap/2024 0 0 monetary I D Short-Term Investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
Repayment Of Financed Insurance Premiums 0000950170-25-068050 1 0 monetary D C Repayment of financed insurance premiums Repayment of financed insurance premiums
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Gain Loss On Disposition Of Assets1 us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Assets Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Interest And Fee Income Other Loans Held For Sale us-gaap/2024 0 0 monetary D C Interest and Fee Income, Loan, Other, Held-for-Sale Amount of interest and fee income from loans held-for-sale and classified as other.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Other Operating Activities Cash Flow Statement us-gaap/2024 0 0 monetary D D Other Operating Activities, Cash Flow Statement Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cost Of Goods And Services Sold us-gaap/2024 0 0 monetary D D Cost of Goods and Services Sold The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Income Taxes Paid us-gaap/2024 0 0 monetary D C Income Taxes Paid Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Long Term Debt us-gaap/2024 0 0 monetary I C Long-Term Debt Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Selling And Marketing Expense us-gaap/2024 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments us-gaap/2024 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Short-Term Investments The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.
Recognition Of Operating Right Of Use Lease Asset 0000950170-25-068050 1 0 monetary D D Recognition of operating right-of-use lease asset Recognition of operating right-of-use lease asset
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Inventory Write Down us-gaap/2024 0 0 monetary D D Inventory Write-down Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Payments Of Stock Issuance Costs us-gaap/2024 0 0 monetary D C Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Increase Decrease In Other Noncurrent Assets And Liabilities Net us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Interest Income Expense Net us-gaap/2024 0 0 monetary D C Interest Income (Expense), Operating Amount of interest income (expense) classified as operating.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Proceeds From Issuance Of Senior Long Term Debt us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Senior Long-Term Debt The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).
Amortization Of Financing Costs us-gaap/2024 0 0 monetary D D Amortization of Debt Issuance Costs Amount of amortization expense attributable to debt issuance costs.
Accrued Interest Income On Short Term Investments 0000950170-25-068050 1 0 monetary D D Accrued Interest Income On Short-Term Investments Accrued Interest Income On Short-Term Investments
Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities 0000950170-25-068050 1 0 monetary D D Capitalized Property, Plant And Equipment Included In Accounts Payable And Accrued Liabilities Capitalized Property, Plant And Equipment Included In Accounts Payable And Accrued Liabilities
Debt Issuance Costs Included In Accrued Liabilities 0000950170-25-068050 1 0 monetary D D Debt issuance costs included in accrued liabilities Debt issuance costs included in accrued liabilities
Non Cash Lease Expense 0000950170-25-068050 1 0 monetary D D Non-Cash Lease Expense Non-Cash Lease Expense
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Amortization Of Intangible Assets us-gaap/2024 0 0 monetary D D Amortization of Intangible Assets The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Amortization Of Discount On Short- Term Investments 0000950170-25-068050 1 0 monetary D D Amortization of Discount on Short-Term Investments Amortization of Discount on Short-Term Investments
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Deferred Income Taxes And Tax Credits us-gaap/2024 0 0 monetary D D Deferred Income Taxes and Tax Credits Amount of deferred income tax expense (benefit) and income tax credits.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Accrued Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Accrued Liabilities, Noncurrent Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Payment Of Exit Fee Costs 0000950170-25-068050 1 0 monetary D C Payment of Exit Fee Costs Payment of Exit Fee Costs
Recognition Of Operating Lease Liabilities 0000950170-25-068050 1 0 monetary D C Recognition of operating lease liabilities Recognition of operating lease liabilities
Increase Decrease In Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Long Term Debt Current us-gaap/2024 0 0 monetary I C Long-Term Debt, Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Payments To Acquire Short Term Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Short-Term Investments The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Provision For Doubtful Accounts us-gaap/2024 0 0 monetary D D Accounts Receivable, Credit Loss Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss on accounts receivable.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000950170-25-068050 2 18 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share_ basic 0
0000950170-25-068050 2 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Revenue 0
0000950170-25-068050 2 2 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 Cost of sales 0
0000950170-25-068050 2 3 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0000950170-25-068050 2 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0000950170-25-068050 2 6 IS 0 H Selling And Marketing Expense us-gaap/2024 Sales and marketing 0
0000950170-25-068050 2 7 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0000950170-25-068050 2 8 IS 0 H Amortization Of Intangible Assets us-gaap/2024 Amortization of intangible assets 0
0000950170-25-068050 2 9 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-068050 2 10 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0000950170-25-068050 2 12 IS 0 H Interest Income Expense Net us-gaap/2024 Interest expense, net 0
0000950170-25-068050 2 13 IS 0 H Interest And Fee Income Other Loans Held For Sale us-gaap/2024 Other adjustment to loan exit fee 0
0000950170-25-068050 2 14 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expenses), net 0
0000950170-25-068050 2 15 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Loss before income taxes 0
0000950170-25-068050 2 16 IS 0 H Income Tax Expense Benefit us-gaap/2024 Provision for (benefit from) income taxes 0
0000950170-25-068050 2 17 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-068050 2 19 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share_ diluted 0
0000950170-25-068050 2 20 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average shares used in computing net loss per share - basic 0
0000950170-25-068050 2 21 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average shares used in computing net loss per share - diluted 0
0000950170-25-068050 3 4 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-068050 3 5 BS 0 H Short Term Investments us-gaap/2024 Short-term investments, held -to-maturity 0
0000950170-25-068050 3 6 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net of allowance for credit losses of $128 thousand and $83 thousand as of March 31, 2025 and December 31, 2024, respectively 0
0000950170-25-068050 3 7 BS 0 H Inventory Net us-gaap/2024 Inventories, net 0
0000950170-25-068050 3 8 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000950170-25-068050 3 9 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-068050 3 10 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property, plant and equipment, net 0
0000950170-25-068050 3 11 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating right-of-use lease assets 0
0000950170-25-068050 3 12 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Intangible assets, net 0
0000950170-25-068050 3 13 BS 0 H Other Assets Noncurrent us-gaap/2024 Other non-current assets 0
0000950170-25-068050 3 14 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-068050 3 17 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0000950170-25-068050 3 18 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued liabilities 0
0000950170-25-068050 3 19 BS 0 H Operating Lease Liability Current us-gaap/2024 Current portion of operating lease liabilities 0
0000950170-25-068050 3 20 BS 0 H Long Term Debt Current us-gaap/2024 Current portion of long-term debt 0
0000950170-25-068050 3 21 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-068050 3 22 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred tax liabilities 0
0000950170-25-068050 3 23 BS 0 H Other Accrued Liabilities Noncurrent us-gaap/2024 Other accrued liabilities 0
0000950170-25-068050 3 24 BS 0 H Long Term Debt us-gaap/2024 Long-Term Debt 0
0000950170-25-068050 3 25 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Long-term operating lease liabilities 0
0000950170-25-068050 3 26 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-068050 3 27 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 16) 0
0000950170-25-068050 3 29 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock, $0.00001 par value, 10,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively, zero shares issued and outstanding at March 31, 2025 and December 31, 2024 0
0000950170-25-068050 3 30 BS 0 H Common Stock Value us-gaap/2024 Common stock, $0.00001 par value, 490,000,000 shares authorized at March 31, 2025 and December 31, 2024, 53,437,060 and 53,409,727 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0
0000950170-25-068050 3 31 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0000950170-25-068050 3 32 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000950170-25-068050 3 33 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity 0
0000950170-25-068050 3 34 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0000950170-25-068050 4 3 BS 1 H Allowance For Doubtful Accounts Receivable Current us-gaap/2024 Allowance for doubtful accounts 0
0000950170-25-068050 4 4 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value 0
0000950170-25-068050 4 5 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0000950170-25-068050 4 6 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0000950170-25-068050 4 7 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0000950170-25-068050 4 8 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0000950170-25-068050 4 9 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0000950170-25-068050 4 10 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0000950170-25-068050 4 11 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0000950170-25-068050 5 8 EQ 0 H Stockholders Equity us-gaap/2024 Beginning Balance 0
0000950170-25-068050 5 9 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Beginning Balance (in shares) 0
0000950170-25-068050 5 10 EQ 0 H Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 Issuance of common stock warrants 0
0000950170-25-068050 5 11 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation 0
0000950170-25-068050 5 12 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Issuance of common stock upon exercise of stock options, shares 0
0000950170-25-068050 5 13 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures us-gaap/2024 Vesting of restricted stock units, Shares 0
0000950170-25-068050 5 14 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-068050 5 15 EQ 0 H Stockholders Equity us-gaap/2024 Ending Balance 0
0000950170-25-068050 5 16 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Ending Balance (in shares) 0
0000950170-25-068050 6 2 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-068050 6 4 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Bad debt expense 0
0000950170-25-068050 6 5 CF 0 H Inventory Write Down us-gaap/2024 Inventory reserve 0
0000950170-25-068050 6 6 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0000950170-25-068050 6 7 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation 0
0000950170-25-068050 6 8 CF 0 H Deferred Income Taxes And Tax Credits us-gaap/2024 Deferred taxes 0
0000950170-25-068050 6 9 CF 0 H Accrued Interest Income On Short Term Investments 0000950170-25-068050 Accrued interest income on short-term investments 0
0000950170-25-068050 6 10 CF 0 H Amortization Of Discount On Short- Term Investments 0000950170-25-068050 Amortization of discount on short-term investments 0
0000950170-25-068050 6 11 CF 0 H Amortization Of Financing Costs us-gaap/2024 Amortization of debt financing costs 0
0000950170-25-068050 6 12 CF 0 H Other Adjustment To Loan Exit Fee 0000950170-25-068050 Other adjustment to loan exit fee 0
0000950170-25-068050 6 13 CF 0 H Non Cash Lease Expense 0000950170-25-068050 Non-cash lease expense 0
0000950170-25-068050 6 14 CF 0 H Gain Loss On Disposition Of Assets1 us-gaap/2024 Loss on disposal of property, plant, and equipment 1
0000950170-25-068050 6 16 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0000950170-25-068050 6 17 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0000950170-25-068050 6 18 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0000950170-25-068050 6 19 CF 0 H Increase Decrease In Other Noncurrent Assets And Liabilities Net us-gaap/2024 Other non-current assets 1
0000950170-25-068050 6 20 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0000950170-25-068050 6 21 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued liabilities 0
0000950170-25-068050 6 22 CF 0 H Other Operating Activities Cash Flow Statement us-gaap/2024 Other 0
0000950170-25-068050 6 23 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Cash used in operating activities 0
0000950170-25-068050 6 25 CF 0 H Payments To Acquire Short Term Investments us-gaap/2024 Purchases of short-term investments 1
0000950170-25-068050 6 26 CF 0 H Proceeds From Maturities Prepayments And Calls Of Shortterm Investments us-gaap/2024 Maturities of short-term investments 0
0000950170-25-068050 6 27 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds from sale of property, plant, and equipment 0
0000950170-25-068050 6 28 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property, plant, and equipment 1
0000950170-25-068050 6 29 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Cash provided by investing activities 0
0000950170-25-068050 6 31 CF 0 H Proceeds From Issuance Of Senior Long Term Debt us-gaap/2024 Proceeds from long-term debt 0
0000950170-25-068050 6 32 CF 0 H Payment Of Exit Fee Costs 0000950170-25-068050 Payment of exit fee costs 1
0000950170-25-068050 6 33 CF 0 H Payments Of Stock Issuance Costs us-gaap/2024 Payments related to equity financing 1
0000950170-25-068050 6 34 CF 0 H Repayment Of Financed Insurance Premiums 0000950170-25-068050 Repayment of financed insurance premiums 1
0000950170-25-068050 6 35 CF 0 H Proceeds From Stock Options Exercised us-gaap/2024 Proceeds from exercise of stock options 0
0000950170-25-068050 6 36 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Cash used in financing activities 0
0000950170-25-068050 6 37 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Change in cash and cash equivalents 0
0000950170-25-068050 6 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0000950170-25-068050 6 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0000950170-25-068050 6 41 CF 0 H Income Taxes Paid us-gaap/2024 Income taxes paid 0
0000950170-25-068050 6 42 CF 0 H Interest Paid Net us-gaap/2024 Interest paid, net of amounts capitalized 0
0000950170-25-068050 6 43 CF 0 H Debt Issuance Costs Included In Accrued Liabilities 0000950170-25-068050 Debt issuance costs included in accrued liabilities 0
0000950170-25-068050 6 44 CF 0 H Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities 0000950170-25-068050 Capitalized property, plant, and equipment included in accounts payable and accrued liabilities 0
0000950170-25-068050 6 45 CF 0 H Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 Issuance of common stock warrants 0
0000950170-25-068050 6 46 CF 0 H Recognition Of Operating Right Of Use Lease Asset 0000950170-25-068050 Recognition of operating right-of-use lease asset 0
0000950170-25-068050 6 47 CF 0 H Recognition Of Operating Lease Liabilities 0000950170-25-068050 Recognition of operating lease liabilities 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.